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Insulin (INS) gene mutations that cause permanent neo-
natal diabetes mellitus change single protein building
blocks (amino acids) in the protein sequence. These
mutations are believed to disrupt the cleavage of the
proinsulin chain or the binding of the A and B chains to
form insulin, leading to impaired blood sugar control. At
least 10 mutations in the INS gene have been identified
in people with permanent neonatal diabetes mellitus.
Objective
To describe clinical features and laboratory manifesta-
tions of patients with INS gene mutation and to evaluate
outcome of management.
Subject and methods
Clinical features, biochemical finding, mutation analysis
and management outcome of 3 cases from 3 unrelated
families were studied. All exons of INS gene were ampli-
fied from genomic DNA and directly sequenced.
Results
3 cases (one girl and two boys) onset at 126.6 ±56.7
days of age with gestation age of 38.0 ± 1.4 weeks, birth
weight of 2850 ± 494.9 g. All of them admitted with the
feature of diabetic ketoacidosis with pH of 6.94 ±0.16;
HCO-3 2.63 ±0.85 mmol/l; BE 26.05±4.03 mmol/l,
plasma glucose levels were 37.57±15.2 mmol/l, HbA1C
of 9.9 ±2.5%. Mutation analysis of the INS gene showed:
heterozygous for a novel missense mutation (c.127T>A;
C43S) in exon 2 of INS gene in one case; heterozygous
for a novel INS splicing mutation, c.188-31G>A of the
INS gene in two cases. After 8 months of insulin treat-
ment, two patients with c.188-31G>A mutation have
normal development with DQ 80-100%, HbA1C of 6.85
±0.49%, quite normal blood glucose levels. The case
with c.127T>A mutation treated with insulin for 8 years
has physical development delay, poor blood glucose con-
trol with HbA1C of 11.4%.
Conclusions
It is important to perform screening gene mutation for
patients with diabetes diagnosed before 6 months of age
to control blood glucose and follow up the patients.
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